Electrical Status Epilepticus of Slow-Wave Sleep

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
1 program
1
Epidiolex 100 mg/mL Oral SolutionPhase 11 trial
Active Trials
NCT04721691Completed16Est. Jan 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Jazz PharmaceuticalsEpidiolex 100 mg/mL Oral Solution

Clinical Trials (1)

Total enrollment: 16 patients across 1 trials

NCT04721691Jazz PharmaceuticalsEpidiolex 100 mg/mL Oral Solution

Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).

Start: Mar 2021Est. completion: Jan 202416 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space